J. Lopez-Campos (Seville, Spain), S. Dragonieri (Bari, Italy), N. Rovina (Athens, Greece), A. Bikov (Miskolc, Hungary)
Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
A. Arnedillo, M. Sanchez-Bommatty, A. Hidalgo-Molina, F. Romero-Valero, J. J. Fernandez-Berni, C. Garcia-Polo, M. Merino-Sanchez, A. Leon-Jimenez (Cádiz, Spain)
|   |
Body mass impacts distal airway function
K. van de Kant, P. Paredi, H. Kalsi, S. Meah, P. Barnes, N. Pride, O. Usmani (Maastricht, Netherlands; London, United Kingdom)
| |
Influence of psychological characteristics of patients for asthma control
J. Perelman, A. Shabanova, L. Bogovin, V. Kolosov (Blagoveshchensk, Russian Federation)
| |
Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study
P. Pompilio, V. Isetta, A. Malinovschi, J. Middlemass, G. Munaro, M. Dalmases, C. Janson, A. N. Siriwardena, R. Macis, P. Zanaboni, P. Calverley, R. Dellaca, R. Rosso (Milano, Vicenza, Italy; Barcelona, Spain; Uppsala, Sweden; Lincoln, Liverpool, United Kingdom; Tromso, Norway)
| |
Associations between muscle wasting and BODE index in chronic obstructive pulmonary disease
M. K. Byun (Seoul, Republic Of Korea)
| |
Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link?
R. Aziz, D. Saralaya, K. Regan, L. Walker (Bradford, United Kingdom)
| |
Obesity influences inflammatory phenotype mainly in early onset severe asthmatics
F. Novelli, L. Vergura, M. Latorre, E. Bacci, M. L. Bartoli, S. Cianchetti, F. L. Dente, A. Di Franco, P. Paggiaro (Pisa, Italy)
| |
Cardiac structure and function at baseline in the DEFLATA study: The impact of lung hyperinflation and its relationship with the GOLD classification
I. S. Stone, W. Y. James, R. Boubertakh, N. C. Barnes, S. E. Petersen (London, Uxbridge, United Kingdom)
| |
Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
J. de Torres, D. Wilson, P. Sanchez, J. Weissfeld, A. B. Alcaide, A. Campo, U. Montes, J. Zulueta (Pamplona, Spain; Pittsburgh, United States Of America)
| |
Correlation of BODE index with extrapulmonary comorbidities of COPD patients
K. Luthra, N. K. Gupta (Udaipur, India)
| |
Factors influencing cognitive function in COPD
E. Dag, E. Bulcun, Y. Türkel, A. Ekici, M. Ekici (Kirikkale, Turkey)
| |
The metabolic syndrome in patients with chronic obstructive pulmonary disease
A. A. Daouud, A. Khoury, L. Shakerdi (Aleppo, Syrian Arab Republic)
| |
Symptoms for anxiety and depression in COPD patients
R. Coelho, A. S. Santos, D. Maia, R. Rosa, V. Caldeira, T. Sá, L. Semedo, J. Cardoso (Lisbon, Portugal)
| |
Left heart dysfunction in acute exacerbation of COPD: Only risk factor or even outcome?
S. Goyal, U. Gampala, D. Srinath, N. Arcot (Chennai, India)
| |
Frequency of depression in patients with chronic obstructive pulmonary disease
M. H. Kamran, M. A. Mushtaq, H. G. Murtaza, M. I. Shehzad, M. Z. Shaheen, S. Shamim, F. Bukhari (Multan, Pakistan)
| |
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
M. Ahmed, K. Leech, B. Rickard, C. Lynch, G. Owen, W. Kempson, M. Allen (Stoke-on-Trent, United Kingdom)
| |
Cardiovascular comorbidity in COPD: Tip of iceberg
G. Chawla, A. P. Kansal, K. Kaur, K. Deep (Patiala, India)
| |
Breath analysis in relapsing polychondritis using ion mobility spectrometry
A. Usuba, H. Handa, T. Inoue, M. Okamoto, M. Minashita, S. Maddula, J. I. Baumbach, T. Miyazawa (Kawasaki, Japan; Dortmund, Germany)
| |
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
M. Westhoff, P. Litterst, H. Sommer, B. Bödecker, J. I. Baumbach (Hemer, Münster, Dortmund, Reutlingen, Germany)
| |